Stocks to buy in 2026 for long term: M&M, UPL among 5 stocks that could 10-20% return
1/6
Brokerage Recommendations
Brokerages remained constructive on a diverse set of stocks spanning automobiles, pharmaceuticals, IT, chemicals and batteries, reiterating their positive outlook despite recent market volatility.
We have collated a list of recommendations from top brokerage firms from ETNow and other sources:
We have collated a list of recommendations from top brokerage firms from ETNow and other sources:
2/6
Morgan Stanley on M&M
Morgan Stanley on M&M: Overweight| Target Rs 4370 (vs Rs 4222)| LTP Rs 3385| Potential Upside 29%
Morgan Stanley maintained its 'Overweight' rating on Mahindra & Mahindra (M&M) and raised the target price to Rs 4,370 from Rs 4,222, indicating a potential upside of around 29% from the current market price of Rs 3,385.
Morgan Stanley maintained its 'Overweight' rating on Mahindra & Mahindra (M&M) and raised the target price to Rs 4,370 from Rs 4,222, indicating a potential upside of around 29% from the current market price of Rs 3,385.
3/6
Citi on Exide Industries Ltd
Citi on Exide Industries Ltd: Buy| Target Rs 510| LTP Rs 444| Potential Upside 14%
Citi reiterated its 'Buy' rating on Exide Industries with a target price of Rs 510, implying a potential upside of about 14% from the current market price of Rs 444.
Citi reiterated its 'Buy' rating on Exide Industries with a target price of Rs 510, implying a potential upside of about 14% from the current market price of Rs 444.
Amazon Top Deals
POWERED BY
4/6
Equirus Securities Ltd on UPL Ltd
Equirus Securities Ltd on UPL Ltd: Long| Target Rs 710| LTP Rs 625| Potential Upside 13%
Equirus Securities maintained its 'Long' stance on UPL with a target price of Rs 710, suggesting a potential upside of around 13% from the current market price of Rs 625.
Equirus Securities maintained its 'Long' stance on UPL with a target price of Rs 710, suggesting a potential upside of around 13% from the current market price of Rs 625.
5/6
Motilal Oswal on Persistent Systems
Motilal Oswal on Persistent Systems: Buy| Target Rs 6400| LTP Rs 5575| Potential Upside 15%
Motilal Oswal retained its 'Buy' rating on Persistent Systems with a target price of Rs 6,400, indicating a potential upside of nearly 15% from the current market price of Rs 5,575.
Motilal Oswal retained its 'Buy' rating on Persistent Systems with a target price of Rs 6,400, indicating a potential upside of nearly 15% from the current market price of Rs 5,575.
6/6
Motilal Oswal on Glenmark Pharma
Motilal Oswal on Glenmark Pharma Ltd: Buy| Target Rs 2570| LTP Rs 2230| Potential Upside 15%
Motilal Oswal also maintained its 'Buy' rating on Glenmark Pharma with a target price of Rs 2,570, implying a potential upside of around 15% from the current market price of Rs 2,230.
(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)
Motilal Oswal also maintained its 'Buy' rating on Glenmark Pharma with a target price of Rs 2,570, implying a potential upside of around 15% from the current market price of Rs 2,230.
(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)